10/10/2025
Techno Biomed Pvt. Ltd. recently hosted a Continuing Medical Education (CME) program at Tikapur Hospital in collaboration with Ayush Surgichem Dhangadhi and in alliance with WERFEN (Autoimmunity) and FENGHUA (Newborn Screening).
Ms. Emily Jing, Product Manager from Fenghua, shared expert insights into critical neonatal screening markers, including:
* Phenylketonuria (PKU): Amino acid metabolism disorder diagnosis
* G6PD Deficiency: Detects enzyme deficiency causing hemolytic anemia
* hTSH (Human Thyroid Stimulating Hormone) T4: Early diagnosis of congenital hypothyroidism
* 17-Alpha Hydroxyprogesterone: Diagnoses congenital adrenal hyperplasia
* Total Galactose (TGAL): Screens for galactosemia
* GALT (Galactose-1-phosphate Uridyl Transferase): Confirms defective galactose metabolism
* Biotinidase: Detects biotin metabolism deficiency
* Immunoreactive Trypsinogen (IRT): Screening for cystic fibrosis
Dr. Vikash Vats, Clinical and Scientific Manager – Autoimmunity at Werfen, provided advanced training on key autoimmune disease markers such as:
* Antiphospholipid Syndrome (anti Cardiolipin (aCL) IgA, IgG, IgM; β2 glycoprotein-1 (β2 GP1) IgG, IgA, IgM variants and Domain 1)
* Celiac Disease (Deamidated gliadin peptide (DGP) IgA, IgG, Screen; Tissue transglutaminase (tTG) IgA, IgG)
* Vasculitis (Glomerular basement membrane (GBM) IgG; Myeloperoxidase (MPO) IgG; Serine protease 3 (PR3) IgG)
* Rheumatoid Arthritis (CCP3 IgG; Rheumatoid Factor IgA, IgM)
* Connective Tissue Diseases (CTD Screen Plus (ANA), ENA7, Centromere, DFS70, dsDNA, HMGCR, Jo-1, Ribosomal P, RNP Ro52, Ro60, Scl-70, Sm, SS-B)
* Liver Disease (LKM-1, M2)
* Gastrointestinal Disease (F***l Calprotectin, Intrinsic Factor)
* Other diseases including Circulating Calprotectin
This CME program marks a significant advancement in diagnostic capabilities for neonatal and autoimmune diseases in Nepal, empowering healthcare providers with cutting-edge technologies and expertise to improve patient care.
